Jonathan Ejie | Personalized Medicine | Best Research Article Award

Jonathan Ejie | Personalized Medicine | Best Research Article Award

Mr. Jonathan Ejie, UCSF, United States

Mr. Jonathan Ejie is an aspiring physician-scientist currently pursuing his M.D. at UCSF 🩺 (Class of 2026), following a B.S. in Electrical Engineering & Computer Science from UC Berkeley 💻. His research spans oncology, radiology, and AI in healthcare, with published work in Cancers (2025) and upcoming studies in Nature Communications 📊. Jonathan integrates data science 🧠 with clinical insights, contributing to health equity, quality improvement, and surgical education. A mentor, tutor, and award-winning leader 🏅, he co-founded the UCSF Futbol Club and serves underserved communities through advocacy and outreach.

Publication Profile 

Orcid

Education

Mr. Jonathan Ejie is an exceptional scholar whose educational journey bridges medicine and technology. He is currently pursuing his Doctor of Medicine (M.D.) degree at the prestigious University of California, San Francisco (UCSF) 🏥, with an expected graduation in 2026. Prior to this, he earned a Bachelor of Science in Electrical Engineering and Computer Science (EECS) 💻 from the University of California, Berkeley, graduating in 2022. His strong foundation in both engineering and clinical science equips him with a unique interdisciplinary perspective 🤖🩺, positioning him at the forefront of innovation in digital health and precision medicine.

Experience

Mr. Jonathan Ejie brings a blend of academic support and compassionate service to his professional journey. As an MCAT Physics Tutor at UCSF (2023), he guided 15+ students through complex physics concepts 📘⚛️. Earlier, at Contra Costa College (2019–2021), he tutored mathematics from Algebra to Calculus ➕📐. His volunteer work includes providing first aid at athletic events 🏃‍♂️🩹, teaching surgical skills to high school students at UCSF 🧵🧑‍⚕️, and serving as a Health Advocate at West County Health Center 💬🩺, helping underserved patients access vital community resources. His dedication reflects a strong commitment to both education and public health.

Awards

Mr. Jonathan Ejie has been recognized for his academic excellence and impactful contributions to medicine and research. In 2024, he was honored with the prestigious Sinkler Miller Medical Association Scholarship 🎖️, sponsored by Gilead, celebrating his commitment to health equity and academic distinction. He also received the UCSF School of Medicine Summer Explore Fellowship Grant 🌟, supporting his innovative pursuits in medical research. In May 2023, Jonathan earned the Inquiry Conference Travel and Dissemination Award ✈️📊, which enabled him to share his scholarly findings on a larger stage. These accolades reflect his rising potential and leadership in healthcare.

Research Focus 

Mr. Jonathan Ejie’s research focus lies at the intersection of oncology, health disparities, and medical data science. His standout work on the “Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer” 📉🩺 highlights critical inequities in healthcare delivery across race, geography, and insurance status. Combining his background in medicine 🧑‍⚕️ and computer science 💻, Jonathan leverages data analysis and machine learning 🤖📊 to drive systemic improvements in cancer care. His work reflects a commitment to equity, evidence-based medicine, and the pursuit of personalized, accessible treatment strategies for vulnerable cancer populations.

Publication Top Notes

  • Ongoing Failure to Deliver Guideline-Concordant Care for Patients with Pancreatic Cancer

Mario Romeo | Precision Medicine | Best Researcher Award

Mario Romeo | Precision Medicine | Best Researcher Award

Dr. Mario Romeo, Dipartimento di Medicina di Precisione, Università degli Studi della Campania, LuigiVanvitelli, Italy

Dr. Mario Romeo is an accomplished medical doctor and researcher specializing in Digestive System Diseases. Graduating with top honors in Medicine and Surgery from the University of Campania “Luigi Vanvitelli” 🎓, he also earned a specialization in Gastroenterology and is pursuing a Ph.D. in Clinical and Experimental Medical Sciences. His research spans gut microbiota 🧫, liver disease 🏥, and metabolic dysfunction. A recipient of over 20 international awards 🏆, Dr. Romeo is widely recognized for his groundbreaking work in hepatology and gastroenterology. He actively contributes to scientific societies and fosters innovation in digestive health care.

Publication Profile 

Orcid

Education

Dr. Mario Romeo 🎓 began his academic journey with honors, earning his Diploma di Maturità Classica from Liceo Classico Gneo Nevio in June 2014 with a perfect score of 100/100 con lode 📜. He continued his excellence at the University of Campania “Luigi Vanvitelli,” completing his Laurea in Medicina e Chirurgia in July 2020 with 110/110 con lode 🩺, presenting a thesis on sarcopenia in compensated liver cirrhosis. He further specialized in Digestive System Diseases, earning his diploma in January 2025 with 50/50 con lode 🌟. His thesis explored RPR as a non-invasive tool in liver disease prediction.

Awards

Dr. Mario Romeo 🏅 has received numerous prestigious scholarships and awards in recognition of his excellence in hepatology and gastroenterology. Highlights include competitive fellowships like the AISF MasterClass 2022 🎓 and UEG Clinical Visiting Fellowship 2025 🌍. He has earned multiple travel grants ✈️ and best presentation prizes 🏆 at top events such as UEG Week, FISMAD, EASL, and ESCI for groundbreaking research on liver diseases, MAFLD, gut microbiota, and non-invasive biomarkers. His multidisciplinary “CoCoNut” protocol 🍏 also gained international acclaim. These accolades affirm his dynamic role in advancing liver research and patient care through innovation and collaboration.

Research Focus 

Dr. Mario Romeo’s research focus lies predominantly in Hepatology and Gastroenterology, with a strong emphasis on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), liver cirrhosis, and gut-liver axis dynamics 🧬🍽️. His work explores non-invasive biomarkers, body composition, oxidative stress, and gut microbiota 🧫, highlighting their roles in disease progression and clinical outcomes. He also investigates multidisciplinary management strategies combining nutritional, psychological, and pharmacological interventions 🥗🧠💊. Dr. Romeo contributes significantly to understanding liver-related complications like sarcopenia, dysgeusia, and hepatocellular carcinoma 🎯. His innovative, patient-centered research enhances predictive diagnostics and therapeutic approaches in chronic liver diseases.

Publication Top Notes

  • Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis
  • Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review
  • Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot?
  • Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  • The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications
  • Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap?
  • Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
  • FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
  • Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the “Bermuda” triangle of malnutrition-sarcopenia-frailty severely affecting prognosis
  • Vanek’s Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report
  • Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece?
  • Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Prof Dr. Piotr Fiedor|Personalized Medicine|Best Researcher Award

Prof Dr. Piotr Fiedor at Department of General and Transplantation Surgery, Medical University of Warsaw,Poland

PROFILE  

 

Scopus

Early Academic Pursuits 🎓

Professor Piotr Fiedor, MD, PhD, embarked on his medical journey with a strong focus on surgery and transplantation. His academic pursuits began at Warsaw Medical University, where he completed his initial medical training. Earning both his MD and PhD, Fiedor developed a passion for complex medical fields such as transplantation immunology and biotechnology. During his early career, he broadened his expertise with international fellowships, notably at Columbia University in the United States, between 1993 and 1996, where he deepened his knowledge in transplantation immunology and immunomodulation. This fellowship solidified his expertise and set the stage for his contributions to both academia and the field of transplantation surgery.

Professional Endeavors 🔬

Professor Fiedor’s professional career has been a blend of clinical practice, research, and leadership roles. Since 1995, he has served in the Department of General and Transplantation Surgery at Warsaw Medical University. His responsibilities in this department include managing clinical procedures, conducting high-level research, and overseeing scientific programs. In addition to his academic role, Fiedor held the prestigious position of Chief Executive Officer at the National Medicine Institute in Warsaw from 2015 to 2017. During this period, he was responsible for overseeing the evaluation of medicinal products, ensuring high-quality standards, and coordinating with the European Directorate for the Quality of Medicines & HealthCare (EDQM).

Fiedor’s influence extends to regulatory affairs, particularly as the Polish Member of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) from 2010 to 2017. His contributions in the CHMP involved acting as Rapporteur or Co-Rapporteur for more than 120 innovative medicinal products, ensuring their safe and effective use across Europe. His regulatory expertise continues, as he now serves as an Expert for the CHMP Scientific Advice Group.

Contributions and Research Focus 🧬

Professor Fiedor’s research has had a profound impact on the fields of transplant surgery, oncology, and immunology. His scientific work has addressed critical challenges in organ transplantation, including the immunological complications of transplants and strategies for improving graft survival. His work on the hemodynamic changes in organ donors before harvesting has been particularly influential, contributing to improved transplantation outcomes.

International collaborations have been a cornerstone of his research. He has worked with institutions like L’Aquila University in Italy, Columbia University and Ohio State University in the United States, and the Hebrew University of Jerusalem in Israel. His participation in 15 national scientific projects supported by Poland’s National Scientific Committee and two research grants from the National Institutes of Health (NIH) in the USA highlight his commitment to advancing medical science on a global scale.

Accolades and Recognition 🏅

Throughout his career, Professor Fiedor has received numerous awards recognizing his contributions to medical science, education, and public health. Some of his most notable honors include:

  • The Gold Cross of Merit awarded by the President of Poland in 2011 for his exceptional service to medicine.
  • The National Education Committee Medal in 2009 for his contributions to the advancement of medical education.
  • Multiple scientific awards from Warsaw Medical University, including team and individual awards for groundbreaking research on organ transplantation and immunology.
  • A notable achievement is his 2012 First-Degree Team Teaching Award from the Rector of Warsaw Medical University for co-authoring a textbook on disaster medicine.

These awards underline his influence on both medical practice and education.

Impact and Influence 🌍

Professor Fiedor’s impact extends beyond his clinical and research achievements. As a member of international organizations like the International Transplantation Society and the American Society of Transplant Surgeons (ASTS), he has helped shape the global discourse on transplant surgery and immunology. His work has led to significant advances in transplantation procedures, particularly concerning immunosuppressive therapies that reduce the risk of organ rejection.

In addition to his clinical and research accomplishments, Fiedor has played a vital role in shaping regulatory policies for medicinal products in Poland and Europe. His expertise in clinical trials, particularly through his work at the National Medicines Institute and his leadership in Good Clinical Practice (GCP) inspections, has influenced the standards of medical product approvals across Europe.

Legacy and Future Contributions 🌟

Professor Fiedor’s legacy lies in his multifaceted contributions to medicine. He has influenced generations of surgeons and medical professionals through his teaching roles at Warsaw Medical University. His over 210 scientific papers and 19 book chapters serve as valuable resources for both current and future medical researchers. His dedication to personalized medicine and biotechnology continues through his involvement in organizations such as the International Consortium for Personalized Medicine (IC PerMed), where he plays a role in advancing tailored healthcare solutions.

Looking forward, Fiedor’s ongoing work with European Joint Programs for Rare Diseases and the National Center for Research and Development’s Alpha Bridge Project ensures that he will continue to contribute to innovative research in the field of rare diseases and healthy society initiatives.

Conclusion 🔖

Professor Piotr Fiedor’s career stands as a testament to his dedication to the fields of surgery, immunology, and transplantation. With a rich history of academic achievements, clinical leadership, and regulatory expertise, his contributions have reshaped modern medicine, particularly in the realms of organ transplantation and medicinal product evaluation. His legacy continues to inspire both his peers and the next generation of medical professionals.

🎓Publication 

One Molecule, Many Faces: Repositioning Cardiovascular Agents for Advanced Wound Healing

  • Authors   : Gościniak, A., Stasiłowicz-Krzemień, A., Michniak-Kohn, B., Fiedor, P., Cielecka-Piontek, J.
  • Journal    :Molecules
  • Year         :2024

Are Current Educational and Therapeutic Programs, Directed at Rare Disease Transplant Candidates and Recipients, Sufficient to Support Them on the Path From Diagnosis to Life After Allogenic Transplantation?—Recommendations for Member State Policymakers

  • Authors   : Bartoszewicz, M., Prokop, P., Kosieradzki, M., Fiedor, P.
  • Journal    :Transplantation Proceedings
  • Year         :2024

Comparison of Long-Term Outcomes of Surgical Treatment of Human Papillomavirus-Dependent Neoplastic Lesions in Patients With Chronic Immunosuppression After Allogenic Organ Transplantation and Patients With Primary or Acquired Immunodeficiency—A One-Center Experience

  • Authors   : Prokop, P., Bartoszewicz, M., Gardyszewska, A., Kosieradzki, M., Fiedor, P.
  • Journal    :ransplantation Proceedings
  • Year         :2024

Amantadine in unvaccinated patients with early, mild to moderate COVID-19: A randomized, placebo-controlled, double-blind trial

  • Authors   :Rejdak, K., Fiedor, P., Bonek, R., Kaczor, M., Grieb, P.
  • Journal    :European Journal of Neurology
  • Year         :2024

POLCOVID: a multicenter multiclass chest X-ray database (Poland, 2020–2021)

  • Authors   :Suwalska, A., Tobiasz, J., Prazuch, W., Cieszanowski, A., Polanska, J.
  • Year         :2023

Assist Prof Dr.Francesco Asnica, Personalized Medicine,Best Researcher Award

Assist Prof Dr.Francesco Asnica,Personalized Medicine ,Best Researcher Award

Assist Prof Dr.Francesco Asnica, at Department CIBIO, University of TrentDepartment CIBIO, University of Trento,Italy

Author Profile

 

Education

  • Ph.D. in Information Technology – Transdisciplinary Programme in Computational Biology (cum laude), University of Trento, Italy (May 2019)
    • Thesis: “A phylogenetic framework for large-scale analysis of microbial communities”
    • Supervisors: Prof. Enrico Blanzieri and Prof. Nicola Segata
  • Master of Science in Computer Science, University of Trento, Italy (October 2014)
    • Thesis: “PhyloPhlAn2 and GraPhlAn: novel reconstruction and visualization tools for large-scale whole-genome phylogenomics”
    • Supervisors: Prof. Enrico Blanzieri and Prof. Nicola Segata
  • Bachelor of Science in Computer Science, University of Trento, Italy (March 2012)
    • Thesis: “Installazione e Test di Estensioni Grafiche Real-time per Debian GNU/Linux”
    • Supervisor: Prof. Luca Abeni

Awards and Honors

  • Highly Cited Researcher 2023 & 2022 in Cross-Field by Clarivate™
  • Member of the Gruppo 2003 per la Ricerca Scientifica since 2023
  • Euregio Young Researcher Award 2022 (Second Place)
  • Co-recipient of the X PRÊMIO 2019 – Prêmio Octavio Frias de Oliveira
  • Doctor Darwin Prize 2017

Fellowships & Scholarships

  • Travel Grant for BITS 2018
  • Summer School Grant for the Second European Summer School on Nutrigenomics 2016
  • Travel Scholarship for ISMB/ECCB 2015

Invited Talks

Dr. Asnicar has delivered numerous invited talks at prestigious conferences and symposiums, including:

  • 9th Central European Congress of Life Sciences Eurobiotech 2024
  • 10th International Human Microbiome Consortium Congress 2024
  • IBS Days 2024
  • DF/HCC Microbiome Symposium Workshop 2024
  • 6th HCMPH Annual Symposium – Microbiome and Cancer 2024

Organized Workshops

  • Workshop on Data Standards, Interoperability, and Model Organisms in Microbiome Research (2023)
  • Workshop on Establishing Consensus for Microbiome Analysis Standards (2023)

🎓Publication Top Noted:

Paper Title : QIIME 2: reproducible, interactive, scalable, and extensible microbiome data science. PeerJ

  • Authors: Evan Bolyen, Jai Ram Rideout, Matthew R Dillon, Nicholas A Bokulich, Christian Abnet, Gabriel A Al-Ghalith, H Alexander, EJ Alm, M Arumugam, F Asnicar, Y Bai, JE Bisanz, K Bittinger, A Brejnrod, CJ Brislawn, CT Brown, BJ Callahan, AM Caraballo-Rodríguez, J Chase, JG Caporaso
  • Journal:Inc
  • Year: 2018
Paper Title : Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals
    • Authors :  Francesco Asnicar, Sarah E Berry, Ana M Valdes, Long H Nguyen, Gianmarco Piccinno, David A Drew, Emily Leeming, Rachel Gibson, Caroline Le Roy, Haya Al Khatib, Lucy Francis, Mohsen Mazidi, Olatz Mompeo, Mireia Valles-Colomer, Adrian Tett, Francesco Beghini, Leonard Dubois, Davide Bazzani, Andrew Maltez Thomas, Chloe Mirzayi, Asya Khleborodova, Sehyun Oh, Rachel Hine, Christopher Bonnett, Joan Capdevila, Serge Danzanvilliers, Francesca Giordano, Ludwig Geistlinger, Levi Waldron, Richard Davies, George Hadjigeorgiou, Jonathan Wolf, José M Ordovás, Christopher Gardner, Paul W Franks, Andrew T Chan, Curtis Huttenhower, Tim D Spector, Nicola Segata
    • Journal:Nature medicine
    • Year: 2021
Paper Title :Human postprandial responses to food and potential for precision nutrition
  • Authors: Sarah E Berry, Ana M Valdes, David A Drew, Francesco Asnicar, Mohsen Mazidi, Jonathan Wolf, Joan Capdevila, George Hadjigeorgiou, Richard Davies, Haya Al Khatib, Christopher Bonnett, Sajaysurya Ganesh, Elco Bakker, Deborah Hart, Massimo Mangino, Jordi Merino, Inbar Linenberg, Patrick Wyatt, Jose M Ordovas, Christopher D Gardner, Linda M Delahanty, Andrew T Chan, Nicola Segata, Paul W Franks, Tim D Spector
  • Journal:Nature medicine
  • Year:2020
Paper Title :Strain-level microbial epidemiology and population genomics from shotgun metagenomics
  • Authors: Matthias Scholz, Doyle V Ward, Edoardo Pasolli, Thomas Tolio, Moreno Zolfo, Francesco Asnicar, Duy Tin Truong, Adrian Tett, Ardythe L Morrow, Nicola Segata
  • Journal:Nature methods
  • Year: 2016

Paper Title :Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

  • Authors: Gladys Ferrere, Maryam Tidjani Alou, Peng Liu, Anne-Gaëlle Goubet, Marine Fidelle, Oliver Kepp, Sylvère Durand, Valerio Iebba, Aurélie Fluckiger, Romain Daillère, Cassandra Thelemaque, Claudia Grajeda-Iglesias, Carolina Alves Costa Silva, Fanny Aprahamian, Déborah Lefevre, Liwei Zhao, Bernhard Ryffel, Emeline Colomba, Monica Arnedos, Damien Drubay, Conrad Rauber, Didier Raoult, Francesco Asnicar, Tim Spector, Nicola Segata, Lisa Derosa, Guido Kroemer, Laurence Zitvogel
  • Journal: JCI insight
  • Year: 2021